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Bu2PC2H4NHCH2Py (PNHN) was synthesized starting from 2-
pyridinecarboxaldehyde and 2-chloroethanamine. Initial attempts for coordination of the 
PNHN ligand to a metal center was performed using [IrCl(COE)2]2, IrCl3·3H2O, 
[RuCl2(p-cymene)]2 and RuCl2(PPh3)3. The reaction between the PNHN ligand and 
[IrCl(COE)2]2 under H2 resulted in the chloride IrCl(H)2(PNHN). Synthesis of the active 
hydride species is currently under investigation. A reaction of the PNHN ligand with 
RuCl2(PPh3)3 under nitrogen afforded the dichloride RuCl2(PPh3)(PNHN). Treatment of 
the dichloride with KOBu
t
 in 2-pentanol led to the formation of the dihydride 
RuH2(PPh3)(PNHN). Formation of the 16-electron amido complex RuH(PPh3)3(PNN) 
was achieved through the evolution of H2. The dihydride demonstrated good potential 
catalytic activity for transfer hydrogenation of acetophenone and cyclohexanone. Current 
work involves the synthesis of a chiral analogue of the PNHN ligand. 
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Chapter 1 
1.1 Introduction and Literature Review 
 The development of new more efficient catalysts for the stereoselective reduction 
of carbonyl compounds represents a current subject of industrial and academic research. 
A wide range of transition-metal complexes have been shown to catalyze hydrogenation 
of ketones. There are two principal ways of adding H2 across a C=O bond: via direct H2-
hydrogenation or transfer hydrogenation. Direct hydrogenation is performed in reaction 
vessels pressurized with hydrogen gas. Catalytic transfer hydrogenation, using 2-
propanol or formic acid as hydrogen donors, allows for new and powerful strategies due 
to the broad applicability and the ease of performance. Chiral catalysts can be used for 
asymmetric hydrogenation to produce enantiomerically enriched secondary alcohols. To 
date homogeneous Ru, Ir, and Rh catalysts have been successfully employed for both 
transfer hydrogenation and asymmetric hydrogenation.
1,2
 One of the earliest catalytic 
methods for the reduction of ketones was reported by Meerwein-Ponndorf-Verley 


































More recent contributions towards the development of new catalysts for transfer 
hydrogenation were reported by Noyori and co-workers. The catalytic hydrogenation 
 2 
processes developed by Noyori and co-workers are very attractive. The precatalysts 
consist of well defined air stable RuCl2(PR3)2(diamine) and RuCl2(diphosphine)(diamine) 
complexes used for the generation of active species for homogeneous transfer and 




 in the presence of a base and 
hydrogen gas.  
 To date, catalytic hydrogenation of ketones is an important fundamental and 
indispensable process for the production of a wide range of alcohols and chiral alcohols. 
These alcohols are valuable end products and precursors for pharmaceutical, 
agrochemical, flavour, fragrance, material, and fine chemical industries. The 
pharmaceutical industry uses asymmetric hydrogenation for the synthesis of new organic 
chemicals, with little to no by-products or wastes. Recent reports have shown that trends 
in the FDA approval of new drug applications shows the percentage of chiral drugs has 
increased from 58 % in 1992 to 75 % in 2006.
8
 This is because enantiomers of chiral 
drugs often have dramatically different activities. Atrovastatin (Scheme 1.2, eq. 1.1), 




Scheme 1.2  
CO2C2H5Cl






















Homogeneously catalyzed ketone hydrogenation has been shown to follow two 
mechanistic pathways. The bifunctional “outer-sphere” mechanism demonstrates 
hydrogenation through the simultaneous transfer of the hydridic M-H and protic N-H 
hydrogens to a C=O bond via a six-atom cyclic transition structure (Figure 1.1, I).
9
 
Alternatively the inner-sphere mechanism takes advantage of an open coordination site 
on the metal that allows for coordination of an unsaturated substrate followed by 
insertion into the M-H bond (Figure 1.1, II).
 9
 Both mechanistic pathways may require 
the presence of a base for catalytic activation generating the catalytically active species. 
Several groups have recently contributed to a better understanding of the hydrogenation 










I II  
Figure 1.1. Proposed transition states of the bifunctional (I) and inner-sphere (II) 
mechanisms. 
 The objective of this research is to prepare new ligands for use in catalytic 
hydrogenation through organometallic chemistry. The goal is to synthesize a family of 
new PNHN pincer-type ligands and their complexes for transfer hydrogenation of 





1.2 Brief History of Transfer Hydrogenation 
In 1968, Knowles and Horner reported the use of a chiral version of  Wilkinson’s 
catalyst RhCl(PPh3)3 for homogeneous hydrogenation.
10  
Since that discovery, much 
attention has been given to the design of transition metal hydrogenation catalysts to attain 
highly efficient molecular transformations for organic synthesis. The bridged 
hydroxycyclopentadienyl ruthenium hydride (Scheme 1.3, 1) was reported by Shvo in 
1986, and was the first successful example of a bifunctional catalyst.
11
 The active catalyst 
is formed through a reaction with H2 (Scheme 1.3). Under H2, the dimer is cleaved 








































 A fundamental contribution to the development of new metal catalysts for transfer 
hydrogenation and asymmetric hydrogenation has been reported by Noyori and co-
workers. Noyori observed that the activity of various ruthenium complexes can be 
enhanced by using primary amine ligands. Two important catalysts (2, 3) reported by 
Noyori are shown in Figure 1.2. In the early 1990’s, Noyori and co-workers developed 
Ru-BINAP complexes which could catalyze both transfer hydrogenation and asymmetric 
hydrogenation. Through manipulation of the accompanying ligand, Noyori reported 























Variations of the Ru-BINAP complexes are used to synthesize chiral secondary alcohols 
used in the pharmaceutical industry (Scheme 1.4). Recently Noyori and co-workers also 
demonstrated that chiral η
6
































Noyori observed that the activity of ruthenium complexes can be enhanced by the 
presence of mutually cis N-H and Ru-H ligands.
12 , 13
 For their work in transfer 
 6 




 Another approach for explaining catalytic transfer hydrogenation is with the 
inner-sphere mechanism. Mizushima and co-workers, Bäckvall, and more recently 
Stradiotto have demonstrated that ketone hydrogenation can be catalyzed by complexes 
possessing no protic NH or OH groups. Mizushima and co-workers showed that cis-
Ru(H)2(PPh3)4 is an active transfer hydrogenation catalyst (Scheme 1.5, eq. 1.3).
14
 It is 
reasonable to assume that at least one PPh3 dissociates during the catalytic reaction, 
opening up a coordination site. Lin and Zhou reported that a variation of Mizushima’s 
catalyst follows the same mechanism and shows higher catalytic activity at room 
temperature. By replacing one of the PPh3 groups with an H2 molecule, the new complex 
Ru(H)2(H2)(PPh3)3 (Scheme 1.5, eq. 1.4) showed an improvement in catalytic activity for 
transfer hydrogenation.
15
 The active catalyst Ru(H)2(PPh3)3 is generated through loss of 
H2 from Ru(H)2(H2)(PPh3)3.
15
 Pàmies and Bäckvall proposed an alternative approach 
involving RuCl2(PPh3)3 as the precatalyst.
16
 The active catalyst Ru(H)2(PPh3)3 (Scheme 
1.5, eq. 1.5) is formed through the reaction of RuCl2(PPh3)3 with a KOH and 2-
propanol.
16
 Loss of one of the PPh3 groups opens a coordination site on Ru where the 













































Beyond these examples, Stradiotto has recently developed a catalyst that demonstrates 
inner-sphere catalysis and also resembles the η
6
-arene-Ru catalyst reported by Noyori 
(Figure 1.3, 3).
17
 Stradiotto’s complex (Figure 1.3, 4) clearly demonstrates that efficient 
transfer hydrogenation can occur without a protic group on the metal. This is achieved 
through dissociation of the amine from the metal centre.
17
 The resulting open 















1.2.1 Bifunctional Mechanism 
 Several groups (Noyori, Morris, Casey) have made much progress in developing a 
good mechanistic understanding of transfer hydrogenation reactions proceeding via the 



































 The catalytic cycle in Scheme 1.6 explains the need for the metal hydride M-H 
and protic N-H group. Through computational and experiment analysis, Noyori has 
shown the importance of mutually cis M-H and N-H groups for bifunctional catalysis. 
Initially the N-H unit forms a hydrogen bond with the oxygen of the carbonyl.
9
 This bond 
helps bring the carbonyl close to the metal hydride.
9
 The ketone substrate then forms a 
six-membered ring intermediate (B) with the metal hydride and protic hydrogen.
18
 DFT 
calculations identify B as the transition state in the gas phase. More recent computational 
work, modeling transfer hydrogenation in solution, suggests that the transition structure B 























Step II completes the transfer of the hydride and protic hydrogens to the C=O, forming a 
secondary alcohol and a 16-electron amido metal complex (C). The amido complex is 
stabilized by a partial double bond between the metal and nitrogen.
9
 From this point, two 
possible paths can be used to regenerate the active catalyst. The first pathway uses H2 gas 
to reduce the partial M-N double bond (step V). Coordination of H2, formation of an 
intermediate dihydrogen complex and subsequent heterolytic cleavage of the H-H bond 
would regenerate the active catalyst.
20
 The heterolytic cleavage of the H2 molecule can 
occur through the four-membered intermediate (5) or the six-membered intermediate (6) 











5 6  
Figure 1.4. Heterolytic cleavage of an H2 molecule intermediates. 
The second pathway (step III) uses 2-propanol as the hydrogen source (formic acid can 
also be used as the hydrogen source). It is proposed that 2-propanol coordinates with the 
amido complex forming a six-membered ring intermediate. The OH group of 2-propanol 







 This is illustrated by the intermediate structure D. Regeneration of the 
 10 
active catalyst is completed by dissociation (IV) of acetone. Specific examples of 
catalysts that follow the bifunctional mechanism will be discussed later. 
 
1.2.2 Inner-Sphere Mechanism 
Well-defined examples of bifunctional catalysts are 18-electron saturated 
complexes, a distinctive feature of the inner-sphere mechanism is that it requires an 






















































This unsaturated catalyst allows for coordination of the substrate ketone directly to the 
metal center. The empty coordination site is a result of ligand dissociation from the 
starting 18-electron metal complex in solution (A). Step I (Scheme 1.8) shows the ketone 
coordinating to the unsaturated metal center (B). An insertion of the substrate into the M-
 11 
H bond affords a new unsaturated metal complex (C).
22
 At this point the hydrogen source, 
2-propanol, can coordinate with the unsaturated metal (step III). This coordination is 
followed by a proton transfer from the OH group of 2-propanol to the oxygen of the 
substrate (D).
22
 The result is the release of a secondary alcohol (step IV) and a new open 
coordination site on the metal center (E). Step V involves a β-H elimination (F) resulting 
in the release of acetone (step VI).
22
 This final step results in the regeneration of the 
active catalyst. A second pathway involves the use of H2 gas as the hydrogen source. 
Coordination of an H2 molecule to the metal center (C) occurs via an open coordination 
site. Subsequent heterolytic cleavage of the coordinated H2 results in the release of a 




1.2.3 Difficulties Determining Mechanistic Pathways 
 Though there are many examples of complexes that follow either the bifunctional 
or inner-sphere mechanisms, determining the correct mechanistic pathway can require 
extensive experimental and computational analysis. The Shvo catalyst is one of the most 
paradigmatic hydrogenation catalysts due to its immense versatility. Its applications in 











 amongst many others. The mechanism of the Shvo 
catalyst has been one of the most controversial in regards to the nature of the hydrogen 
transfer. Shvo and coworkers showed that with activation of the catalyst using H2, 
transfer hydrogenation occurs through the concerted outer-sphere mechanism (Scheme 
1.9, I).
23
 Regeneration of the active catalyst is achieved through one of two possible 
pathways. The first being formation of complex 1 (Scheme 1.9) from II followed by 
 12 
subsequent activation with H2.
23
 The second pathway involves coordination of one 
















































 Recently, computational analysis by Casey’s and Bäckvall’s group has given rise 
to alternative catalysis mechanisms. In 2001, Casey’s group used the tolyl analogue of 
the Shvo catalyst [2,5-Ph2-3,4-Tol2(η
5
-C4OH)]Ru(CO2)H and analyzed the effects of the 
primary deuterium isotope on the hydrogenation of PhCHO.
28
 They concluded that the 
hydrogenation goes through the concerted bifunctional mechanism. Bäckvall’s work 





































Comas-Vives and coworkers investigated both proposed mechanisms with the 









 ring slippage would have an energy barrier of 34.6 kcal/mol 
in solution.
28




 transfer of the bifunctional mechanism 
resulted in an energy barrier of 7.7 kcal/mol in solution.
28
 With these results, it was 
concluded that the bifunctional mechanism presented the most favourable energy 
pathway. Through computational and experimental analysis it seems to be clear that the 
bifunctional mechanism is more feasible. 
 Beyond the Shvo catalyst, Baratta and coworkers reported the synthesis of 








They reported that with the active catalyst, an NH
…
O=C interaction results 
activating the substrate towards nucleophilic attack and provides the ketone with the 
orientation needed for transfer of the hydride (Scheme 1.11).
30
 This resulting alkoxide 
 14 
anion can then migrate from the hydrogen to the metal center affording the Ru-alkoxide 
intermediate 16.
30
 The theoretical studies performed by Baratta and coworkers also 
supported this mechanistic pathway.
30
 The reversibility of the alkoxide formation when 
using benzophenone provides evidence that the Ru-alkoxide is an intermediate in the 


















The two aforementioned catalysts illustrate the difficulties that can arise when attempting 
to determine the correct mechanistic pathway of a reaction. 
 
1.3 Bifunctional Catalysts 
 Using transition metal catalysts, the kinetics, TOF and ee of reactions following 
the bifunctional mechanism have been reported extensively. An ideal catalyst should 
have high TOF’s for a wide range of substrates, and the reactions should be easy to 
perform, safe, and environmentally friendly.
31
 
 Noyori and Ohkuma disclosed the catalyst 2 as being efficient for asymmetric 
hydrogenation of a large variety of ketones.
31
 In the general reaction (Scheme 1.12) 2 was 


















Manipulations to the accompanying ligand allowed them to perform asymmetric 
hydrogenation on ketones with a range of functional groups including aromatic and 
alkene groups. These reactions were used to verify the versatility of the Ru-BINAP 
complex. Figure 1.7 lists some of the results demonstrating high enantioselectivity. 
99 % ee 100 % ee 97 % ee 94 % ee 97 % ee
OH OH OH OH OH
 
Figure 1.7. Alcohols produced by transfer hydrogenation of ketones using 2, K2CO3 or 
KOBu
t






Though a major goal is to achieve high enantiomeric selectivity, numerous 
complexes have been reported showing high TOF. This is important when the aim is to 
achieve high yields using minimal catalyst loadings. With the pharmaceutical industry 
emphasis is placed on producing secondary alcohols with high enantiomeric selectivity. 
Conversely, in an industry where high enantiomeric selectivity is not as vital, high TOF 
values are more desirable. This is the case with the oil and gas industry where catalysts 



















7 8  
Figure 1.8 
 Many sophisticated bi-, tri-, and tetradentate achiral and chiral ligands have been 
successfully used to prepare five- and six-coordinate complexes for transfer 







 (NPN = oxazoline based ligands), and 
[RuCl2(PNNP)] (PNNP = diphosphine/diamine ligand).
35
 More recently, Baratta reported 
the synthesis of an N-heterocyclic carbene ruthenium catalyst 7 (Figure 1.8). This catalyst 
showed high activity in a series of transfer hydrogenation reactions with various ketones 
(Figure 1.9) demonstrating high TOF values. 
OH
Yield = 99 % (5)
TOF = 110000 h-1
OHOH
Yield = 98 % (2)
TOF = 120000 h-1
Yield = 96 % (10)




Yield = 99 % (5)
TOF = 100000 h-1
OH
Cl
Yield = 90 % (10)
TOF = 50000 h-1  
Figure 1.9. Alcohols produced by transfer hydrogenation at 82 
o
C, 0.1 M of ketone in 2-
propanol with NaOH and 7 (2000:1:40).
36
 
In 2007, Del Zotto and Baratta reported the synthesis of the complex 
[RuCl2(PPh3)(PNN’)] 8 (Figure 1.8).
37
 This complex successfully catalyzed transfer 
hydrogenation of numerous ketones with a very high rate (TOF up to 250 000 h
-1
) (Figure 
1.10). The high activity of this complex suggests that the imine fragment of the PNN 
 17 








Yield = 98 % (2)
TOF = 185000 h-1
Yield = 99 % (1)
TOF = 250000 h-1
Yield = 99 % (1)
TOF = 240000 h-1
Yield = 97 % (5)
TOF = 70000 h-1
Yield = 93 % (10)




Figure 1.10. Alcohols produced by transfer hydrogenation at 82 
o
C, 0.1 M of 
acetophenone in 2-propanol with (CH3)2CHONa and 8 (1000:1:40).
37
 
 Del Zotto noted that efficient catalysis with [RuCl2(PPh3)(PNN’)] was observed 
with the presence of the chloride atom in the ortho position resulted in lower TOFs (70 
000 h
-1
). This trend was rationalized to be the result of steric hindrance, which is 
kinetically relevant when the chloride was located in the ortho position.
37
 
 Transfer hydrogenation has also been shown to perform in conjunction with other 
catalytic reactions. Morris developed a Ru-BINAP complex to promote a Michael 
addition followed by enantioselective transfer hydrogenation according to Scheme 1.12. 
Motivation for this work came from an earlier report that showed borohydride complexes 
of the make-up trans-RuH(η
1
-BH4)(BINAP)(diamine) are active catalysts for asymmetric 
hydrogenation of ketones without activation using a base.
38
 The resulting product alcohol 
(Scheme 1.12) was obtained as a 30:1 mixture of the trans and cis isomers; the preferred 






































 The complexes surveyed in this chapter are just a few of a number of known 
catalysts that demonstrate good catalytic activity with the NH moiety required by the 
bifunctional mechanism. 
 
1.4 Inner-Sphere Catalysts 
 Recently, catalysts have been developed that show comparable TOF values and 
yields to bifunctional catalysts while following the inner-sphere mechanism. In a report 
published by van Koten and co-workers in 2007, the synthesis and catalytic activity of 
the PCP-pincer Ru(II) complex is described (Figure 1.11).
39
 The complexes catalytic 
activity was tested through transfer hydrogenation of cyclohexanone (Figure 1.12). By 
varying the groups on phosphorus, they noted a change in TOF values ranging from 8 















TOF = 33600 h-1 (10) TOF = 8000 h
-1 (30) TOF = 35700 h-1 (10)
R = Ph R = MeOC6H4 R = CF3C6H4  
Figure 1.12. R represents the groups on phosphorus in 10. Reactions done at 82 
o
C, with 




The active catalyst is formed by reacting 10 with NaOiPr in 2-propanol at 82 
o
C 
affording 11. They determined that the catalytic cycle starts by coordination of the ketone 
substrate to the Ru-hydride intermediate 12 giving I (Scheme 1.13). This coordination is 
followed by the intermolecular addition of the hydride to the α-C atom of the ketone II.
39
 
2-propanol releases the coordinated alkoxide through protonation forming the secondary 
alcohol III and IV. The catalytic cycle is completed with a hydride transfer from the 
isopropoxide via β-H elimination (V) followed by the exchange of acetone with another 




























































 Another interesting example of inner-sphere catalysis was reported by Stradiotto 
and co-workers. Stradiotto developed a zwitterionic ruthenium complex (Scheme 1.14) 
that is one of the most active transfer hydrogenation catalysts for ketones to date.
17
 When 
used in reactions with alkyl and aryl ketones, this catalyst demonstrated very high TOF 


















 The mechanistic pathway for transfer hydrogenation catalyzed by 13 has been 
extensively studied by Gusev and Stradiotto with the help of DFT calculations.
40
 
Activation of the precatalyst (I) is achieved with KOBu
t
 in 2-propanol (Scheme 1.15)
40
 
resulting in the formation of a 2-propoxide complex (II). Dissociation of NMe2 from Ru 
opens up a coordination site on Ru (III). The new 16-electron 2-propoxide intermediate 

























I II III IV  
 To determine the catalytic activity of 13, Stradiotto performed transfer 
hydrogenation using several ketones (Figure 1.13). The resulting TOF values are some of 








TOF = 180000 h-1
t(min) = 5
TOF = 220000 h-1
t(min) = 15
TOF = 180000 h-1
t(min) = 5
TOF = 180000 h-1
t(min) = 15
TOF = 150000 h-1  
Figure 1.13. Alcohols produced by transfer hydrogenation using of 0.1 M of ketone, 13 






1.6 Research Plan 
 Based on the literature precedent for the need of a versatile catalyst for transfer 
hydrogenation, methods to prepare catalysts and analyze their reactivity are proposed. 
The anticipated strategy for the preparation of transition metal catalysts is to first 
synthesize a new PNHN pincer-type ligand (Scheme 1.16, eq. 1.6). Upon successful 
synthesis of the proposed PNHN ligand, precatalyst metal complexes will be prepared 
through coordination with selected transition metals (Ru, Ir, Os, Re). The metal 
complexes will then be investigated for transfer hydrogenation of ketones and production 
of secondary alcohols. With successful completion of these studies, synthesis of a new 
chiral PNHN ligand will commence (Scheme 1.16, eq. 1.7). The new chiral ligand will be 
coordinated with the previously mentioned transition metals. These metal complexes will 
then be employed for asymmetric hydrogenation of ketones and the production of chiral 
secondary alcohols. 

















































2.1 Preparation of New Pincer-Type Ligand 
The first attempt toward the synthesis of the new PNHN ligand involved a 















(2.1) (2.2) (2.3) 91 %  
In this reaction the product observed by NMR was (E)-2-chloro-N-((pyridine-2-




H} NMR through the 
disappearance of the C=O peak at 188.9 ppm and the appearance of a peak at 164.6 ppm 
of the imine carbon. Isolation of the product first required the removal of water produced 
by this reaction. Removal of water was done to avoid any potential hydrolysis of the 
imine group regenerating the starting aldehyde 2.1. Crystallization of the product was 
accompanied with an impurity present as a singlet at δ 1.35 in the 
1
H NMR spectrum. 
Standard purification techniques were unsuccessful in the removal of the impurity. The 
addition of PBu
t

























Initial attempts at synthesizing the PNHN ligand (2.4) resulted in the formation of an 
aziridine (2.5). The formation of the aziridine is believed to occur through a nucleophilic 
attack by the PBu
t
2 on the electrophilic carbon of the imine. This attack is followed by a 
second nucleophilic attack by the resulting amide on the carbon bonded to the chlorine 




H} NMR and an 
overlapped singlet at δ 3.39 in the 
1
H NMR spectrum supports the formation of the 
aziridine. Attempts to avoid this formation involved the addition of LiPBu
t
2 to the 
reaction solution at -80 
o
C and using ClPBu
t
2 in the presence of Li or Zn. In both cases 
the competing attack on the imine forming the aziridine was more favourable than the 
desired reaction. 
To avoid the formation of 2.5, it was decided to start with the addition of PBu
t
2 to 
2.2. The synthesis required protection of the nitrogen to avoid any reactivity between 
LiPBu
t
2 and the NH2 group (Scheme 2.3).
41
 To overcome this problem two TMS groups 















2) rt. 72 h
(2.2) (2.6) 64 %
HCl
 
Protection of the nitrogen gave the product 2.6 as a clear colourless liquid with a 64 % 
yield. Additionally the protection of the nitrogen competes with self-alkylation and 
alkylation between two molecules of 2.2, even when the reaction is done at low 
temperature. Attempts to optimize the reaction have shown no increase in the amount of 
recovered product. 
1
H NMR showed a singlet at δ 0.02 representing the two TMS 
protecting groups on the nitrogen and no evidence of the NH2 group. Addition of PBu
t
2 
was achieved by reacting 2.6 with LiPBu
t








1) -35 C, 30 min
2) rt. 3 h
3) reflux 1 h








2 was achieved by the addition of ClPBu
t
2 to a suspension of 
lithium granules in THF with stirring for 72 h. With the reaction flask in a cold bath, 2.6 
was added dropwise to the LiPBu
t
2/THF solution. Precautions had to be taken due to the 
exothermic nature of this reaction. Water was then used to quench the reaction. The 
resulting protected amino phosphine (2.7) was isolated with ca. 15 mol% of the (PBu
t
2)2 




H} NMR spectrum.  
The first attempt at deprotection of the amino phosphine was done employing 
TBAF (Scheme 2.5). It is well known that thermal decomposition of TBAF produces n-
 27 
butene and tributylamine hydrofluoride.
42
 This decomposition occurs by E2 elimination 
where the fluoride ion acts as a strong base. Removal of these impurities was 
unsuccessful due to the similarities in the boiling points and solubility of tri-n-butylamine 
and 2.8. The presence of tri-n-butylamine was visible in the 
1
H NMR spectrum at δ 2.35 




H} NMR spectrum showed single peaks at δ 54.3, 29.8, 20.9 and 













To avoid contamination by tributylamine, alternative deprotecting agents were employed. 
The use of Me4NF, Et4NF and NH4F was. In all cases no evidence of deprotection was 
observed. Since the decomposition of TBAF and formation of HF in the reaction mixture 
was responsible for the deprotection of 2.7, it was decided to use triethylamine 










2)K2CO3 (1 equiv.), 





After stirring at room temperature overnight, K2CO3 was added to help isolate 2.8. 
Analysis of the 
1
H NMR spectrum confirmed the removal of the protecting groups and a 
new singlet at δ 3.42 for the NH2 group. Isolation of 2.8 resulted in a clear colourless 
liquid with a yield of 77 %. The completion of the ligand backbone called for a 
condensation reaction between 2.8 and 2.1 (Scheme 2.7). 
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(2.4) 96 %  
1.1 equivalents of 2.1 were added dropwise to the reaction solution over 5 min. 
Continuous stirring at room temperature over 1 h afforded the PNN ligand 2.4. 
Evaporation under vacuum gave the product as a clear dark orange oil at near quantitative 
yield (96 %). Characterization using NMR techniques showed the presence of 2.4. Before 
attempting to reduce the imine group, coordination chemistry using 2.4 was investigated. 
 
2.2 Coordination of PNN Ligand to Ir and Ru 
 As reported by Del Zotto and Baratta, complexes with a ligand system such as 
2.4 have been shown to demonstrate high activity toward transfer hydrogenation. 
Reduction of the imine would be accomplished through activation of the catalyst. With 
the ligand 2.4 in hand, coordination chemistry was done by employing the transition 
metals Ir and Ru. Initial attempts of coordination with Ir were done using [IrCl(COE)2]2 














The reaction between 2.4 and [IrCl(COE)2]2 was done using 0.45 equivalents of the Ir 
dimer. The expected structure would be formed through a cleavage of the dimer followed 
by displacement of one cyclooctene (2.9). The groups L and L
’
 each represent one of 
either nitrogen group or the phosphorus group of 2.4. The reaction produced a precipitate 
which was believed to be 2.9 since the solution contained no evidence of the phosphorus 
group. Characterization of the precipitate was not completed due to poor solubility. 



















The first attempt of the reaction in Scheme 2.9 was done under N2 and left stirring 
overnight. With the completion of the reaction a precipitate formed. NMR showed that 
the reaction solution again contained no phosphorus. Again any attempts to characterize 
the solid were unsuccessful due to poor solubility. Since it is know that N2 can react with 
Ir complexes, the reaction was repeated under H2. Characterization was not completed 
due to poor solubility. 
Coordination of 2.4 with Ru was then attempted using [RuCl2(p-cymene)]2 







































90 C, 1 h
eq. 2.2
 
Shown in the square brackets are the proposed structures of the resulting ruthenium 
complexes (Scheme 2.10). As was the case with Ir, the solubility of the expected products 
did not allow for proper characterization. Varying the reaction conditions of the Ir and Ru 
coordination reactions showed no improvement with the solubility of the complexes. It 
was decided the reduction of the imine group in 2.4 before coordination could improve 
the solubility of the metal complexes. 
 
2.3 PNHN Ligand 
Reduction of the imine group would result in the formation of the protic hydrogen 
required for the bifunctional mechanism. Reduction of the imine group employing a 
number a reducing agents (NaBH4, LiAlH4, Super hydride, lithium aluminum tri-tert-
butoxy hydride, Pt/c, Pd/c and Raney-Ni) showed reduction of the imine but eventually 
DIBAL-H (Scheme 2.11) was used because of more convenient isolation/purification of 













(2.4) (2.13)  
Simply quenching the reaction with water resulted in 2.13 which was isolated by 
removing the precipitate using filtration and evaporation of the solvent. The resulting 
PNHN ligand was obtained as a clear light orange oil with a yield of 91 %. With this new 





 groups of all Ir metal complexes have been omitted for clarity reasons. 
3.1 Iridium Chloride 
 Equal amounts of 2.13 and [IrCl(COE)2]2 were dissolved in toluene and left 
stirring under nitrogen for 30 min. The nitrogen was then evacuated and replaced with H2 
gas through a series of freeze-pump-thaw cycles. The H2 gas is used as the hydride source. 
After 1 h of stirring under H2, the reaction solution was left overnight. This resulted in the 
displacement of cyclooctene and the formation of a new complex containing the 


















The product was obtained as a pale green solid with the presence of residual solvent. 











H} NMR due to poor solubility. From the 
1
H NMR spectrum, the 
doublet at δ 9.08 was indicative of the CH-N fragment in the pyridine ring. The 
remaining CH groups a multiplet at δ 7.72, a doublet at δ 7.26 and a triplet at δ 7.17. The 
distinct downshift of the CH-N resonance is believed to be caused by the coordination of 
the nitrogen to the metal center. Due to the C1 symmetry of 3.0 all CH2 protons of the 
PNHN ligand are magnetically inequivalent. NOE decoupling revealed that the broad 
singlet belonged to the NH group coordinated to the metal center. This experiment 
identified the CH2 groups bound on either side of the NH. The 
1
H NMR spectrum showed 
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doublets of doublets at δ 4.81 and 3.99 of the CH2 bonded to pyridine and the central 
nitrogen. The multiplets at δ 3.54 and 2.59 belong to the other CH2 group bonded to the 
central nitrogen. Finally, the CH2 group bonded to phosphorus was identified by the 
doublet of doublets at δ 2.33 and the multiplet at δ 2.06. The shifts for the Bu
t
 groups on 
phosphorus showed as a doublet at δ 1.32 in the 
1
H NMR spectrum due to overlap of the 
Bu
t
 resonances. Finally the metal complex exhibited hydride resonances at δ -19.89 and -
25.28 as doublets of doublets. The coupling constants between the hydrides and 
phosphorus are 
2
JHP = 17.7 Hz and 21.9 Hz. The coupling constant between the hydrides 
is 
2
JHH = 7.5 Hz which is typical for hydrides cis to each other. The IR spectrum of 3.0 
showed a band at 3363 cm
-1









H} NMR spectrum showed a singlet at δ 
54.0 of the coordinated phosphorus. Interestingly all reactions performed also showed 
accompanying isomers of the desired product. From the 
1
H NMR spectrum shifts which 
were slightly shifted and similar to the major product were visible. The resonances at δ -




H} NMR spectrum showed a singlet at δ 63.2 also belonging to the isomer. DFT 
calculations suggested that there are three possible isomers of the expected product. The 
isomers are meridional syn IrCl(H)2(PNHN) (Figure 3.1, 3.0), meridional anti 
IrCl(H)2(PNHN) (Figure 3.2, 3.1) and facial IrCl(H)2(PNHN) (Figure 3.3, 3.2). The 
calculated enthalpies of the isomers are 0 kcal/mol for 3.0, 1.3 kcal/mol for 3.1 and 5.1 
kcal/mol for 3.2. The relatively low energies of 3.0 and 3.1 further supports their 
presence. The enthalpy for 3.2 is high enough to suggest that this isomer would not be 
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expected to form. In the accompanying diagrams most of the hydrogen atoms have been 





Figure 3.1 illustrates the DFT structure representing the meridional syn 
IrCl(H)2(PNHN) complex. The PNHN ligand defines the plain. The hydride Ha is shown 
in the plain and trans to the central nitrogen (N1). The second hydride Hb is trans to the 
chloride (Cl). The two Bu
t
 groups on the phosphorus (P) are slightly bent away from the 
chlorine atom due to a slight steric interaction. The main structural feature is that the 
chlorine atom and the protic hydrogen are on the same side of the plain thus located syn 












The second isomer shown in Figure 3.2 represents the DFT calculation structure 
of the meridial anti IrCl(H)2(PNHN) metal complex. Again the PNHN ligand defines the 
plain. The hydride Ha is trans to the central nitrogen (N1). The two Bu
t
 groups are seen 
slightly bent away from the chloride because of sterics. The second hydride Hb and the 
protic hydrogen Hp are located on the same side of the plain. With this complex the 
chloride is now positioned anti to the protic hydrogen.  
 
3.2 Iridium Dihydride 
 Previous synthesis of iridium complexes (3.3) done in our group used KOBu
t
 to 
perform the dehydrochlorination affording the amido complex 3.4 (Scheme 3.2, eq. 
3.1).
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 Further reactivity of the amido complex under 1 atm of H2 gave the trihydride (3.5) 

















































(3.4) (3.5)  
Initially synthesis of the trihydride from the isomers 3.0 and 3.1 was attempted using the 
same process outlined in eq. 3.1 and eq. 3.2. Unfortunately there was no formation of the 
desired hydride complex 3.5. Instead of KOBu
t
, Super hydride was employed to perform 






















The reaction solution turned pale yellow after 1 h stirring at room temperature. 
Characterization using 
1




H} NMR revealed the formation of the 
trihydride along with the amido complex shown in Figure 3.4. The presence of the amido 
complex is possibly due to loss of H2.
43
 Separation of 3.5 or 3.6 for characterization 
purposes was achieved. The 
1
H NMR spectrum showed hydride shifts at δ -8.48 and -
8.97. These hydride shifts belong to H’ and H” of complex 3.5 (Figure 3.4). The hydride 
shift at δ -16.78 belongs to the hydride trans to the central nitrogen. The apparent 
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symmetry of 3.6 is Cs where the PNN atoms define the ligand plain. Thus the two Bu
t
 and 
two hydrides are pairwise equivalent in the NMR spectra as well as the hydrogens of the 
CH2 groups in the PNHN ligand backbone. Analysis of 
1
H NMR spectrum showed a shift 
at δ -23.59 for the hydrides of 3.6 (Figure 3.4). Due to the poor solubility of complexes 





showed a shift at δ 63.8 of the phosphorus group of 3.6 and δ 57.6 of the phosphorus 



















Since separation was incomplete, catalysis was performed using a solution 
containing both complexes. Complexes 3.5 and 3.6 were tested for hydrogenation of 
representative ketones using 
1
H NMR to monitor the reactions. A mixture of 3.5 and 3.6 
in THF reacted with acetophenone and cyclohexanone at room temperature in 2-propanol 
showed no hydrogenation. Due to the poor solubility of the complexes and the inactivity 
towards catalysis, attention was turned to synthesis of ruthenium complexes for 





 groups of all Ru metal complexes have been omitted for clarity reasons. 
4.1 Ruthenium Dichloride 
4.1.1 Synthesis using [RuCl2(p-cymene)]2 
 Initial preparation of the ruthenium chloride represented by the proposed structure 
4.1 was done using the starting complex [RuCl2(p-cymene)]2. Equal amounts of the 
PNHN ligand and [RuCl2(p-cymene)]2 in the presence of 4 equivalents of 2, 6-lutidine 
were dissolved in 2-propanol. The reaction solution was heated overnight at 90 
o
C with 
stirring (Scheme 4.1). The resulting product was formed as clear reddish platelet crystals. 
Isolation of the crystals was done by decanting and drying under vacuum. 
1
H NMR 




H} NMR did 















(2.13) (4.1)  
To improve the solubility of the product, the crystalline material was used to prepare the 
proposed ruthenium hydride 4.2. Preparation of the ruthenium hydride was attempted by 
using KOBu
t



























H} NMR for the reaction using Bu4NBH4 showed the formation of a 




H} NMR for the reaction using KOBu
t
 showed the 
formation of one major product at δ 112.5. The 
1
H NMR showed a broad hydride shift at 
δ -16.69 representing the equivalent hydrides of the expected metal complex. Since the 
product had low solubility in THF, complete characterization of the complex was not 
achieved. There was also no indication of the protic hydrogen. Attempts at producing a 
tetra hydride species (4.3) by performing the reaction using KOBu
t
 under H2 gas 
(Scheme 4.3) resulted in multiple shifts in the hydride region on the 
1


















4.1.2 Synthesis using RuCl2(PPh3)3 
 With the unsuccessful synthesis of the ruthenium chloride (4.1) using [RuCl2(p-
cymene)]2, attention was turned to using RuCl2(PPh3)3 as the starting complex for the 
synthesis of a ruthenium dichloride complex. The PNHN ligand and RuCl2(PPh3)3 were 
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dissolved in toluene and left stirring for 3 h under nitrogen. Isolation of the resulting light 
orange coloured solid afforded the ruthenium dichloride 4.4 with a yield of 89 % 

















rt. 3 h under N2
(2.13)
 






H NMR provide clear 




H} NMR spectrum showed 
two doublets, one at δ 52.9 and the other at δ 40.1. The two-bond coupling constant of 
2
JPP = 21.1 is indicative of two phosphorus groups cis to one another. The structural 
conformation of the ligand was determined to be facial with the PBu
t
2 group located 
above the metal centre and trans to one of the chlorides. The correct structure of the 
complex was not determined due to the difficulties of growing crystals for XRD analysis. 
The facial configuration is supported by 
1
H NMR data. Examination of the 
1
H NMR 
spectrum of 4.4 revealed a unique shift at δ 8.50 and further downshifted from the rest of 
the pyridine shifts. Analysis using NOE showed that the shift was of the proton CH-N 
group of the pyridine ring. This unique shift also showed an interaction with protons from 
the triphenylphosphine group found at δ 7.08, interaction with the NH group found at δ 
5.78 and with the PBu
t





spectrum provides the necessary information to suggest that the phosphorus groups are 
cis and that the triphenylphosphine group is trans to the central nitrogen. Further 
investigation of the 
1
H NMR spectrum provided information supporting the expected C1 
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symmetry of the complex through the magnetically inequivalent hydrogens of the CH2 





analysis could not be performed. The IR spectrum shows a peak at 3186 cm
-1
 of the NH 
group. With the synthesis of the dichloride preparation of the dihydride began. 
 
4.2 Ruthenium Dihydride 
 Initial attempts toward the synthesis of the ruthenium dihydride complex 
employed Super hydride. One equivalent of Super hydride was added to the ruthenium 




H} NMR showed multiple peaks with two major 
ones representing the wanted hydride species. The 
1
H NMR spectrum only showed 
hydride shifts belonging to the product. Unfortunately attempts at isolation were 
ineffective. Attention turned to previous synthesis of dihydrides performed in our group 
with the use of KOBu
t
 and 2-propanol (Scheme 4.5). The final dihydride complex 4.5 is a 
























Upon addition of KOBu
t
 the resulting solution turned a dark green colour. After 1 
h of stirring at room temperature the reaction mixture turned a dark brownish-orange. 
After stirring overnight a fine light orange precipitate formed. Isolation was achieved 
with evaporation of the solvent and drying under vacuum. The product precipitate was 




H} NMR spectrum showed the formation of two 
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complexes. The major complex showed doublets at δ 104.0 and δ 69.4. The coupling 
constants were 
2
JPP = 291.6 Hz for both doublets. The large coupling constant is 
indicative of two phosphorus groups located trans to each other. The minor complex has 
doublets at δ 79.8 and δ 78.9. The coupling constant is 
2
JPP = 7.1 Hz for both doublets. 
The relatively small coupling constant is a result of the two phosphorus groups located 
cis to each other. The 
1
H NMR spectrum showed two multiplets in the hydride region at δ 
-18.02 and δ -18.51 belonging to the major species. There was also a multiplet at δ -16.43 
which belonged to the minor species. Analysis of the hydride region showed the presence 
of a dihydride and what appeared to be a monohydride species. Due to residual solvent 
from the reaction and washing, proper characterization could not be done on the sample 
prepared in 2-propanol. The reaction was repeated but with 2-pentanol as the solvent. 
With 2-pentanol the solubility of the complexes decreased allowing for better isolation of 
the product. A similar procedure was followed using 2-pentanol instead of 2-propanol. 
The product was obtained as a brownish orange solid with a minimal amount of residual 





spectrum showed that the doublet at δ 104.0 belonged to the PBu
t
2 group and the doublet 
at δ 69.4 belonging to the PPh3 group. The 
1
H NMR spectrum again showed the 
aforementioned chemical shifts in the hydride region as multiplets. The symmetry of the 
dihydride is C1 and thus the hydrogens of the CH2 groups are magnetically inequivalent. 
With the use of standard NMR techniques it was determined that the two products 






















In the reaction using 2-propanol it was believed that the minor product was a 
monohydride species. With the use of 2-pentanol complete characterization of both 
species revealed that the minor species was the dihydride complex 4.5 and the major 
complex was 4.6. The 
1
H NMR spectrum now showed a multiplet at δ -7.72 and at δ -
16.43 both belonging to the minor dihydride complex. The DFT calculated structure 






The DFT calculated structure of the minor complex shows the two phosphorus 
groups (P1 and P2) cis to each other. The triphenylphosphine group (P2) is located trans 
to the central nitrogen (N2) and the PBu
t
2 group (P1) is located trans to the hydride Ha. 
This structure also shows the location of the hydrides (Ha and Hb) cis to one another. The 
hydride Hb is located trans to the nitrogen (N1) of the pyridine ring. This results in an 
overall facial structure of the ruthenium dihydride complex with atoms N1, N2, P2 and 
Hb all in the same plain and P1 located above the plain. Figure 4.4 illustrates the DFT 












The DFT calculated structure for the major dihydride shows the two phosphorus 
(P1 and P2) groups trans to each other. The phosphorus groups (P1 and P2) are located 
above and below the metal center. As with the minor ruthenium dihydride, the hydrides 
are also located cis to one another. The difference being that Ha is now trans to the 
central nitrogen (N2) instead of the triphenylphosphine group (P2).  
To fully characterize the complexes, crystals were grown through slow diffusion 
of hexane into a solution of toluene containing the ruthenium dihydride complexes. The 
resulting crystal structure, of the major dihydride, is illustrated in Figure 4.4. Due to the 









the crystal structure. The difficulty with improving the crystal structure is believed to be 
caused by interference from the minor dihydride.  
 
Figure 4.4 
With both structures fully characterized, the complexes were then used in 
catalysis reactions.  
 
4.2.1 Transfer Hydrogenation of Ketones 
 An NMR tube reaction mixture (S:C = 250:1) containing acetophenone (300 mg), 
2-propanol (1 mL) and catalytic amounts of the ruthenium dihydride (6 mg) showed 
reasonable transfer hydrogenation of the ketone to the expected 2-phenylethanol at room 
temperature without the addition of a base. Due to the limited solubility of the dihydride 
in 2-propanol, a solution of acetophenone and 2-propanol was prepared first followed by 















































































In the first two cases formation of 2-phenylethanol and cyclohexanol where 
observed by 
1
H NMR. Cases three and four showed less than 10 % formation of the 
secondary alcohol while cases five and six showed no reactivity. It can be concluded that 
the catalytic activity of the ruthenium dihydride complex is low. In an attempt to better 
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understand the reactivity of the dihydride, isolation of the resulting amido complex after 
transfer hydrogenation of the ketone was attempted. 
 
4.2.2 Ruthenium Amido Complex 
 With both the bifunctional mechanism, the transfer of the hydridic and protic 
hydrogens to the ketone forms a 16-electron amido complex. The inner-sphere 
mechanism involves the coordination of a ketone to an empty coordination site on the 
metal complex. This complex is usually reduced by an alcohol solvent to regenerate the 
starting catalyst. To better understand why the catalysis employing the ruthenium 
dihydride is not efficient, isolation of the amido complex was attempted.  
In a J. Yung NMR tube the ruthenium dihydride was dissolved in THF. Freeze-
pump-thaw cycles were performed every 30 min with intermittent heating at 50 
o
C for 5 
min periods. By placing the ruthenium dihydride under vacuum, H2 was slowly liberated 
















(4.6) (4.7)  
With the liberation of the H2 molecule from the ruthenium dihydride, a structural change 
occurred resulting in the phosphorus groups now located cis to each other with the ligand 
backbone now meridial. The purpose of this experiment was to gain a better 
understanding of the structural nature of the 16-electron complex. The resulting amido 
complex was obtained in solution with a conversion of 70 %. This change in the 
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H} NMR spectrum. The phosphorus 
shifts were now located at δ 109.8 and δ 73.8 as doublets. The coupling constant for the 
new phosphorus shifts is 
2
Jpp = 16.5 Hz respectively which is indicative of phosphorus 
groups cis to each other. The 
1
H NMR spectrum showed the presence of a doublet of 
doublets at δ -19.52 representing the hydride of the amido complex. Exploration into the 
removal of the triphenylphosphine group and replacing it with a carbonyl group was 
investigated. The replacement of the triphenylphosphine group with the carbonyl group 
could improve the catalytic ability of the dihydride. 
 
4.3 Ruthenium Carbonyl Complex 
 In order to improve the catalytic activity of the ruthenium dihydride an alternative 
synthesis involving a carbonyl group in place of the triphenylphosphine was implemented. 
Morales-Morales and coworkers developed the following synthesis to replace one of the 
























Addition of the carbonyl ligand is interesting due to its sensitivity to electronic density 
changes and the relative ease for identification of the carbonyl group through NMR and 
IR techniques. By simply stirring a solution of RuCl2(PPh3)3 in DMF under carbon 
monoxide complex 4.8 is obtained. Complex 4.8 was obtained as a pale yellow solid with 




H} NMR spectrum both triphenylphosphine groups 
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showed as a single shift at δ 35.9. From the 
1
H NMR spectrum the coordinated 
dimethylformamide was identified at δ 2.23 as overlapped doublets representing the two 
methyl groups and at δ 6.81 representing the CH group. Unfortunately the solubility 4.8 




H} NMR. It can however be said 
with certainty that the complex is the desired complex since the NMR shifts are in 
reasonable agreement with the reported values. The IR spectrum of 4.8 showed a broad 
peak at 1913 cm
-1
 belonging to both carbonyl groups. 
 A solution of 4.8 in glyme was then treated with the PNHN ligand and allowed to 
stir for 4 h at 90 
o
































The resulting ruthenium dichloride (4.9) was isolated as a yellow solid with a yield of 




H} NMR spectrum showed a singlet at δ 86.5 representing the 
phosphorus group. The 
1
H NMR spectrum gave the expected shifts of the pyridine ring 
with the CH-N proton at δ 8.94 downshifted from the other three protons. There was no 
evidence of coordinated triphenylphosphine. Due to the C1 symmetry of the complex, the 
protons of the CH2 groups are magnetically inequivalent. Complete characterization was 




H} NMR spectrum where the carbonyl group was visible at δ 
203.8 as a doublet. The IR spectrum showed a peak at 1929 cm
-1
 representing the 
carbonyl group and a peak at 3178 cm
-1
 of the NH group. Interestingly, 4.9 showed high 
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stability in the polar solvent dimethylsulphoxide. The synthesis of the hydride has not yet 


























It is believed that the dihydride demonstrates loss of H2 immediately resulting in a 





H} NMR shows a shift at δ 122.4 of what is believed to be the monohydride complex. 
This is supported by a doublet in the hydride region of the 
1
H NMR spectrum at δ -17.06. 




5.1 Chiral PNHN Ligand 
 Attention turned to the preparation of a new chiral PNHN ligand. The goal was to 
add an isopropyl group to the CH2 group on the phosphine side of the central nitrogen. 
With the addition of the isopropyl group there is potential for improved solubility and 
asymmetric hydrogenation of various ketones. Addition of the isopropyl group would be 
achieved by employing commercially available L-valinol. Initial attempts to add the 
PBu
t
2 group to L-valinol proved unsuccessful. It was decided to use a previously reported 
synthesis of an amino alcohol (5.4) by Cleij and coworkers to prepare the backbone for 
the chiral PNHN ligand (Scheme 5.1).
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 The asterisk denotes the chiral center for all 










5 Å molecular sieves
CH2Cl2 (100 mL)
rt. 3 h
(5.1) (5.2) (5.3)  
Filtration followed by evaporation of the solvent under vacuum afforded a clear 
colourless oil containing 5.3. Reduction of the imine group was done through the reaction 
of 5.3 with sodium borohydride in ethanol overnight (Scheme 5.2) affording the desired 




















The chiral ligand 5.4 was obtained as a clear pale yellow oil with a 94 % yield.  
Confirmation of the structure was verified with the presence of the multiplet at δ 2.47 of 
the CH group bonded to the central nitrogen. The coordinated isopropyl group gave a 
multiplet at δ 1.82 of the CH group and doublets at δ 0.96 and 0.90 of the CH3 groups. 
All other shifts agreed with the reported values. The synthesis continued with the 
















After refluxing for 1 h the resulting amino chloride was filtered and isolated as a beige 
solid with a yield of 42 %. Due to the poor solubility of 5.5 in chlorinated solvents, 
DMSO had to be used for proper characterization. The 
1
H NMR spectrum shows all the 
expected peaks with the exception of a broad peak at δ 9.98 belonging to the NH2 group. 
The shift representing the CH2 group bonded to the pyridine ring is now a singlet at δ4.57. 
Finally the addition of the chloride atom to the ligand is confirmed with presence of the 




H} NMR spectrum also confirms the 
presence of the CH2Cl group with the appearance of a peak at δ 41.4. Optimization of this 
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reaction has failed to increase the overall yield of 5.5. Due to the poor solubility of 5.5 in 
chlorinated solvents, recovery of the product was done by washing with methylene 
chloride and filtration. Problems could also be associated with the length of time needed 
for reflux. Further experimentation is required to determine the proper reaction conditions. 
With the amino chloride ligand isolated, the addition of the PBu
t
2 group was investigated. 
 As with the synthesis of the PNHN ligand precautions had to be taken to insure no 
reaction between PBu
t
2 and the central nitrogen occurred. Without a protecting group on 
the central nitrogen the formation of the aziridine is expected. It was decided to try and 
add a protecting TMS group to the central nitrogen by reacting the amino chloride with 


















The protection reaction did not produce the desired product. Most of 5.5 remained 
unreacted due to limited solubility. To improve the solubility of 5.5 TMS-Cl was used as 
the solvent. The solubility of 5.5 improved but 
1
H NMR analysis revealed that self-
alkylation had occurred producing the aziridine. The preference towards self-alkylation 
can be attributed to two factors; the first is that the sterics caused by the isopropyl group 
would not allow addition of the TMS group and the second is that the reaction producing 
the aziridine is more favourable. With these two factors it was decided to react 5.5 with 
LiPBu
t
2 without the addition of the protecting group (Scheme 5.5). With the low reaction 
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temperature and sterics caused by the isopropyl group, a reaction between 5.5 and 
LiPBu
t















Addition of the solvent was done through vacuum transfer with the reaction mixture 
cooled to -80 
o
C. The reaction mixture was left stirring for 1 h. It was then removed from 
the cold bath and left stirring at room temperature for 30 min. Finally the reaction 
mixture was refluxed for 30 min. The purpose of the lower temperature at the beginning 
of the reaction was to decrease the rate of aziridine formation. To remove excess LiPBu
t
2 




H} NMR spectrum 
showed one peak at δ 21.1 which is indicative of HPBu
t
2 and no peak representing the 
PBu
t
2 group of 5.7. Analysis of the final product using 
1
H NMR revealed no formation of 
5.7 and a mixture of unreacted 5.5 and the aziridine.  
Recently Babu and coworkers reported successfully using zinc powder to 
deprotonate an amino acid methyl ester hydrochloride salt.
47
 TMSCl was then added as a 
protecting group during the synthesis of the peptide. Since 5.5 displays similar 
characteristics to the hydrochloride salt used by them, it was decided to attempt a similar 




















The overall yield of the final product was not determined due to the presence of 
unreacted zinc. The 
1
H NMR spectrum showed the coordination of zinc to the amino 
chloride. The shifts of the pyridine ring were as expected. No evidence of aziridine 
formation was indicated by the spectrum and a multiplet at δ 3.88 represented the CH2Cl 
group. Coordination of zinc to the amino chloride was apparent with the splitting of the 
NH group at δ 3.72 where the broad shift was now a multiplet. With ZnCl2 acting as a 
protecting group on 5.8, investigations for the addition of PBu
t
2 started with reacting 5.8 
directly with LiPBu
t

















Vacuum transfer of the solvent to the reaction flask was performed. The resulting 
reaction mixture was left stirring for 1 h at -80 
o
C and 1 h at room temperature. NMR 
analysis showed there was no formation of 5.9. Determining of the exact nature of 5.8 
and the correct reaction scheme are still being investigated.  
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A final attempt for addition of the phosphine group was performed by reacting the 
amino alcohol (5.4) with ClPBu
t





















H} NMR showed a peak at δ 150.6 belonging to ClPBu
t
2. Altering the reactions 




 In conclusion the synthesis and complete characterization of a new PNHN ligand 
(2.13) through simple organic reactions has been reported. Further studies showed the 
successful coordination of the PNHN ligand to iridium and ruthenium transition metals. It 
was discussed that the characterization and catalysis of the iridium hydrides (3.5 and 3.6) 
was hindered due to poor solubility and the inability to separate the metal complex. 
Successful characterization of the ruthenium dichloride (4.4) and dihydride (4.7) was 
achieved. Transfer hydrogenation of various ketones was then attempted using 4.7. Some 
catalytic activity was observed with acetophenone and cyclohexanone at low rates. An 
investigation for isolation and characterization of complex 4.8 revealed a structural 
changed by the ligand from facial (4.7) to meridional (4.8) during catalysis. Synthesis 
employing RuCl2(PPh3)3 to produce the ruthenium carbonyl complex (4.9) reported by 
Morales-Morales and coworkers was used. With the ruthenium dichloride 4.10, synthesis 
of the ruthenium dihydride was attempted. Preparation of the dihydride was not achieved 
due to the loss to H2. Further experimental investigation of the hydride ruthenium 
carbonyl complex is underway. With the use of the synthesis for the amino alcohol (4.5) 
by Cleij and coworkers a new chiral amino chloride (5.5) was produced. Studies into the 
addition of the phosphine group and the completion of a new chiral PNHN ligand for 





6.2 Future Work 
 With promising results from the coordination chemistry of 2.13 with ruthenium 
and iridium, syntheses of the new chiral PNHN ligand has become our goal. By 
employing L-valinol we were able to obtain the backbone structure of the desired ligand. 
To date the difficulty has been with the addition of the phosphine group. Alternative 
methods being explored for the addition of the phosphine group include exploring a ring 
opening reaction involving 2-isopropylaziridine (6.1) (Scheme 6.1). 
Scheme 6.1 














Deprotection of 6.3 would be achieved be employing TBAF or Et3N•3HF depending our 
success toward isolation of 6.4. Completion of the chiral PNHN ligand (2.13) will 
involve the condensation reaction between 6.4 and 2-pyridine-carboxaldehyde (2.1) 





























With the completion of 2.13, coordination chemistry would involve the use of the same 
starting metal complexes [IrCl(COE)2]2, [IrCl3·3H2O]2, [RuCl2(p-cymene)]2 and 


















The catalytic ability of the chiral metal complex will then be analyzed by performing 
asymmetric hydrogenation on various ketones. The catalytic cycle is expected to follow 

























































Sterics caused by the bulky Bu
t
 groups on the phosphine and the isopropyl group will 
help with the selectivity of the products. The groups Rs and Rb represent the small and 
bulky groups of the substrate. It is reasonable to expect that the substrate would 
preferably approach the catalyst with the Rb group pointing away from the bulky Bu
t
 
groups (step I); therefore the final product should be mostly one enantiomer of the chiral 
alcohol RsRbCHOH. For example the hydrogenation of acetophenone is expected to give 
(S)-1-phenylethanol as the main product. Regeneration of the active chiral catalyst will 
result from transfer hydrogenation involving a molecule of 2-propanol and the 
unsaturated amido complex (step II). Finally variations of the chiral PNHN ligand will be 
explored using other polar and non-polar amino acids. This is because the group at the 
chiral center can have a range of different effects on the efficiency of the catalyst due to 
sterics. Amino acids of interest are Leu (R = CH2Pr
i




7.1 Experimental Section 
7.1.1 General Considerations 
 All preparations and manipulations were carried out under nitrogen, argon, 
hydrogen or carbon monoxide atmospheres with the use of gloveboxes, vacuum line and 
standard Schlenk flasks. Standard solvents and deuterated solvents were degassed and 
dried before use in reactions. Starting materials and reagents were purchased from 





 C NMR chemical shifts were measured relative to the solvent peaks. A Perkin-
Elmer Spectrum BXII FT IR spectrometer was employed to obtain infrared spectra for 







(Me3Si)2N(CH2)2Cl: A 1 L flask was charged with H2N(CH2)2Cl•HCl (20.0 g, 172.4 
mmol), triethylamine (80 mL, 568.8 mmol) and 220 mL of CH2Cl2. The reaction solution 
was cooled to 0 
o
C and trimethylchlorosilane (50 mL, 379.3 mmol) in 80 mL of CH2Cl2 
was added in portions over a 5 min period to the reaction flask with vigorous stirring. The 
reaction mixture was stirred for 72 h. After filtration, CH2Cl2 was evaporated under 
vacuum and the product was extracted from the resulting oil with 3 x 30 mL of hexane. 
Hexane was evaporated under vacuum to give 24.5 g (109.5 mmol, 64 %) of 
(Me3Si)2N(CH2)2Cl as a clear colourless liquid. 
1
H NMR (C6D6): δ 3.13 (m, 2H, CH2Cl), 




H} NMR (C6D6): δ 48.09 (s, CH2Cl), 









 (13.0 g, 71.9 mmol) was added in ca. 2 g portions to a stirred 
suspension of lithium granules (1.5 g, 216.0 mmol) in THF (50 mL). Each subsequent 
portion was added when the mixture cooled to or near room temperature.  The resulting 
mixture was then stirred vigorously for 72 h. The mixture was then filtered and cooled to 
-35 °C and a solution of (Me3Si)2N(CH2)2Cl (9.0 g, 40.2 mmol) in 10 mL of THF was 
added dropwise over a 10 min period. The mixture was removed from the cold bath after 
30 min, stirred for 3 h at room temperature and refluxing for 1 h. Water (40.0 mL) was 
added to the reaction flask and stirring continued for 1 h. Further washing of the solution 
 64 
was done with three 5.0 mL portions of water.  The resulting aqueous layer was removed 
and the solvent evaporated under vacuum giving (Me3Si)2N(CH2)2PBu2
t












H} NMR (C6D6): δ 40.6). Deprotection of the amino phosphine was 
achieved using Et3N•3HF (3.1 g, 19.5 mmol) with triethylamine (11.8 g, 117.2 mmol) in 
50 mL of CH2Cl2. The mixture was left stirring overnight. K2CO3 (4.1 g, 29.3 mmol) was 
then added and the resulting heterogeneous mixture was stirred for 3 h. CH2Cl2 was 
evaporated and 20 mL of hexane was added to the flask. The hexane solution was filtered 
followed by evaporation of hexane under vacuum. H2N(CH2)2PBu2
t
 was isolated by 
distillation (b. p. = 29 – 39 °C, 0.01 mmHg)  and obtained as a clear colourless liquid, 
(3.7 g, 19.8 mmol, 77 %). 
1
H NMR (C6D6): δ 3.42 (s, 2H, H2N), 2.80 (dt, 
3
JHH = 9.0, 2H, 
H2NCH2), 1.38 (m, 2H, CH2P), 1.07 (d, 
3




H} NMR (C6D6): δ 
43.79 (d, 
2
JCP = 29.9, H2NCH2), 31.52 (d, 
1
JCP = 21.6, PC), 30.22 (d, 
2
JCP = 13.9, CH3), 
27.45 (d, 
1










Ligand): To a solution of H2N(CH2)2PBu2
t
 (3.7 g, 19.7 mmol) in 30 mL of THF, 2-
pyridine-carboxaldehyde (2.3 g, 21.7 mmol) was added dropwise over a 5 min period 
with stirring. The reaction solution was left stirring for 1 h followed by evaporation of the 
solvent and subsequent drying for 4 h under vacuum. The product was obtained as a clear 
dark orange oil (5.3 g, 96 %). 
1
H NMR (C6D6): δ 8.62 (s, 1H, CHN), 8.48 (m, 1H, Py), 
8.21 (m, 1H, Py), 7.07 (m, 1H, Py), 6.64 (m, 1H, Py), 3.83 (m, 2H, NCH2), 1.78 (m, 2H, 
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CH2P), 1.05 (d, 
3




H} NMR (C6D6): δ 162.45 (s, CHN), 
156.26 (s, Py), 149.96 (s, Py), 136.32 (s, Py), 124.71 (s, Py), 121.15 (s, Py), 63.07 (d, 
2
JCP 
= 34.6, NCH2), 31.66 (d, 
1
JCP = 22.1, PC), 30.09 (d, 
2













2-(di-tert-butylphosphino)-N-((pyridin-2yl)methyl)ethanamine (PNHN Ligand):  To 
a solution of the PNN Ligand (4.2 g, 15.1 mmol) in 20 mL of hexanes, DIBAL-H (2.5 g, 
17.4 mmol) was added dropwise over a 10 min period with continuous stirring. The 
resulting dark brownish red solution was left stirring for 1 h. The reaction solution was 
then quenched with the dropwise addition of degassed water (1.6 g, 87.1 mmol) over a 10 
min period with continuous stirring. The resulting orange mixture was left stirring for 30 
min followed by evaporation and drying for 4 h under vacuum. The PNHN ligand was 
isolated as a clear light orange oil (3.8 g, 15.1 mmol, 91 %). 
1
H NMR (C6D6): δ 8.45 (d, 
3
JHH = 4.5, 1H, Py), 7.13 (s, 1H, Py), 7.06 (m, 1H, Py), 6.59 (m, 1H, Py), 3.91 (s, 2H, 
CH2NH), 2.82 (q, 
3
JHH = 7.8, 2H, NHCH2), 1.85 (s, 1H, NH), 1.52 (m, 2H, CH2P), 1.02 
(d, 
3




H} NMR (C6D6): δ 161.78 (s, Py), 149.81 (s, Py), 
136.17 (s, Py), 122.23 (s, Py), 121.91 (s, Py), 56.11 (s, CH2NH), 51.07 (d, 
2
JCP = 31.2, 
NHCH2), 31.5 (d, 
1
JCP = 22.0, PC), 30.12 (d, 
2
JCP = 13.9, CH3), 23.29 (d, 
1

















IrH2Cl(PNHN). The PNHN ligand (180.0 mg, 0.6 mmol) was added to a solution of 
[IrCl(COE)2] (280.0 mg, 0.6 mmol) in 5 ml of toluene. The reaction solution was stirred 
under nitrogen for 30 min. 3 freeze – pump - thaw cycles were used to refill the flask 
with H2 and stirring continued for 1 h at room temperature. H2 was then evacuated and 
the solution was left stirring under vacuum overnight. The mixture was filtered and 
washed with 3 x 2 mL of hexane and dried under vacuum for 3 h. 163 mg of 
IrH2Cl(PNHN) and residual solvent was obtained as a pale green solid. IR (KBr cm
-1
): 
vNH = 3363 (s), vIrH = 2273 (s), 2185 (s). 
1
H NMR (CD2Cl2): δ 9.08 (d, 
3
JHH =  5.7, 1H, 
Py), 7.72 (m, 1H, Py), 7.26 (d, 
3
JHH = 7.8, 1H, Py), 7.17 (t, 
3
JHH = 6.6, 1H, Py), 4.81 (dd, 
3
JHH = 14.7, 
2
JHH = 4.2, 1H, PyCH2), 3.99 (dd, 
3
JHH = 14.7, 
2
JHH = 10.8, 1H, PyCH2), 4.37 
(m, 1H, NH), 3.54 (m, 1H, NHCH2), 2.59 (m, 1H, NHCH2), 2.33 (dd, 
3
JHH = 15, 
2
JHH = 
4.8, 1H, CH2P), 2.06 (m, 1H, CH2P), 1.32 (d, 
2





JHH = 7.5 1H, IrH), -25.28 (dd, 
2
JHP = 21.9, 
2
















RuCl2(PPh3)(PNHN). A solution of RuCl2(PPh3)3 (432.0 mg, 0.4 mmol) and the PNHN 
ligand (132.0 mg, 0.4 mmol) was stirred in 8 mL of toluene for 3 h under nitrogen at 
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room temperature. The resulting solid was filtered and washed with 3 x 2 mL of toluene. 
The solid was dried under vacuum for 3 h affording RuCl2(PPh3)(PNHN) as light orange 
coloured solid (281.0 mg, 0.4 mmol, 89 %). IR (KBr cm
-1
): vNH = 3186 (s). 
1
H NMR 
(C6D6): δ 8.50 (m, 1H, Py), 8.23 (m, 6H, PPh3), 7.08 (m, 9H, PPh3), 6.64 (dt, 
3
JHH = 1.8, 
7.8, 1H, Py), 6.36 (d, 
3
JHH = 7.5, 1H, Py), 6.01 (t, 
3
JHH = 6.3, 1H, Py), 5.78 (s, 1H, NH), 
5.25 (t, 
3
JHH = 12.9, 1H, PyCH2), 3.22 (m, 1H, PyCH2), 3.06 (m, 1H, NHCH2), 2.58 (m, 
1H, NHCH2), 1.96 (m, 2H, CH2P), 1.26 (d, 
2
JHP = 11.7, 9H, CH3), 1.15 (d, 
2





H} NMR (C6D6): δ 52.9 (d, 
2
JPP = 21.1, 1P, RuP), 40.1 (d, 
2













 (73.0 mg, 0.6 mmol) was added to RuCl2(PPh3)(PNHN) 
(221.0 mg, 0.3 mmol) dissolved in 15 mL of 2-pentanol.The solution was left stirring 
overnight at room temperature. The resulting dark redish brown mixture was evaporated 
under vacuum. A brownish orange solid (205.0 mg, 0.3 mmol) was obtained with 
residual 2-pentanol and KCl contaminate. IR (KBr cm
-1
): vNH = 3308 (s), vRuH = 1909 (s, 
overlapped), 1888 (s, overlapped). 
1
H NMR (THF-d8): δ 8.05 (d, 
3
JHH = 5.4, 1H, Py), 
7.56 (m, 6H, PPh3), 7.05 (m, 9H, PPh3), 7.01 (m, overlapped, 1H, Py), 6.69 (d, | 
3
JHH = 
7.5, 1H, Py), 6.11 (t, 
3
JHH = 6.0, 1H, Py), 3.69 (m, 2H, PyCH2), 3.41 (m, 1H, NH), 2.70 
(m, 1H, NHCH2), 2.60 (m, 1H, NHCH2), 1.87 (m, 1H, CH2P), 1.74 (m, 1H, CH2P), 1.45 
(d, 
2
JHP = 11.7, 9H, CH3), 1.12 (d, 
2





H} NMR (THF-d8): δ 160.3 (d, 
3
JCP = 1.4, CN), 156.0 (d, 
3
JCP = 1.4, 
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CHN), 143.1 (dd, 
1
JCP = 27.9, 
3
JCP = 1.5, PPh3), 134.3 (d, JCP = 11.6, PPh3), 130.3 (s, Py), 
127.7 (d, JCP = 7.8, PPh3), 127.5 (d, JCP = 1.4, PPh3), 122.9 (s, Py), 119.0 (s, Py), 58.5 (s, 
PyCH2N), 53.8 (dd, 
3
JCP = 3.9, 10.5, NCH2), 38.3 (dd, 
1
JCP = 5.2, 
3
JCP = 2.7, PC), 31.0 (d, 
2
JCP = 7.6, CH3), 24.5 (d, 
1




H} NMR (THF-d8): δ 104.1 (d, 
2
JPP = 
291.6, 1P, RuP), 69.4 (d, 
2







RuH(PPh3)(PNN). A sample of RuH2(PPh3)(PNHN) (25.0 mg) in THF-d8 was prepared 
in a J. Jung NMR tube. Freeze – pump – thaw cycles were repeated every 30 min with 
intermittent heating at 50 °C for 5 min. The resulting amido complex was obtained in 
solution (70 %). 
1
H NMR (THF-d8): δ 7.68 (m, 6H, PPh3), 7.45 (d, 
3
JHH = 5.7, 1H, Py), 
7.24 (m, overlapped, 1H, Py), 7.16 (m, 9H, PPh3), 7.05 (m, overlapped, 1H Py), 6.18 (t, 
3
JHH =  6.3), 4.52 (m, 2H, PyCH2), 3.42 (m, 1H, NCH2), 3.09 (m, 1H, NCH2), 2.27 (m, 
CH2P), 2.06 (m, 1H, CH2P), 1.22 (d, 
2
JHP = 11.4, 9H, CH3), 0.58 (d, 
2
JHP = 11.7, 9H, 
CH3), -19.52 (dd, 
2
JHP = 51.3, 
2




H} NMR (THF-d8): δ 170.3 
(d, 
3
JCP = 1.4, CN), 155.8 (d, 
3
JCP = 1.4, CHN), 143.2 (d, JCP = 29.6, PPh3), 136.2 (d, JCP 
= 10.5, PPh3), 133.2 (s, Py), 128.6 (d, JCP = 1.7, PPh3), 127.7 (d, JCP = 8.2, PPh3), 120.3 
(d, JCP = 2.2, Py), 119.2 (s, Py), 43.0 (s, broad, CH2N), 37.9 (m, PC) 34.9 (m, PC), 30.4 
(d, 
2
JCP = 5.5, CH3), 30.0 (d, 
2





NMR (THF-d8): δ 109.8 (d, 
2
JPP = 16.5, RuP), 73.8 (d, 
2

















 A mixture of RuCl2(PPh3)3 (2.0 g, 2.1 mmol) in 15 mL of 
dmf was stirred for 1 h under carbon monoxide at room temperature. The resulting pale 
yellow suspension was filtered and washed with 3 x 15 mL of ether. Subsequent drying 
under vacuum for 3 h afforded RuCl2(CO)(PPh3)2(dmf) as a pale yellow solid (1.4 g, 2.1 
mmol, 83 %). IR (KBr cm
-1
): vCO = 1913 (s), vCN = 1631 (vs). 
1
H NMR (CD2Cl2): δ 7.72 
(m, 12H, PPh3), 7.38 (m, 18H, PPh3), 6.81 (s, 1H, CH(DMF)), 2.26 (s, 3H, CH3(DMF)), 













RuCl2(CO)(PNHN). PNHN (384.0 mg, 1.4 mmol) was added to RuCl2(CO)(PPh3)(dmf) 
(994.0 mg, 1.2 mmol) dissolved in 15 mL of glyme. The solution was left stirring at 90 
o
C for 4 h. The resulting mixture was then cooled to room temperature and left stirring 
overnight. The solid material was filtered and washed with 3 x 2 mL of ether. The solid 
was then dried for 4 h affording RuCl2(CO)(PNHN) as a yellow solid (464.0 mg, 1.2 
mmol, 88 %). IR (KBr cm
-1
): vNH = 3178 (s), vCO = 1929 (s), vCN = 1607 (vs). 
1
H NMR 
(CD2Cl2): δ 8.94 (m, 1H, Py), 7.73 (m, 1H, Py), 7.32 (m, overlapped, 1H, Py), 7.29 (m, 
overlapped, 1H, Py), 5.16 (m, 1H, NH), 4.87 (m, 1H, PyCH2), 4.51 (m, 1H, PyCH2), 3.67 
(m, 1H, NHCH2), 3.37 (m, overlapped, 1H, NHCH2), 2.52 (m, 1H, CH2P), 2.24 (m, 1H, 
CH2P), 1.45 (d, 
3
J = 12.9, 9H, CH3), 1.38 (d, 
3






(CD2Cl2): δ 203.8 (d, 
2
J =  14.2, CO), 161.6 (s, CN), 153.9 (s, CH), 137.8 (s, CH), 124.9 
(d, 
3
JCP = 2.1, CH), 122.1 (d, 
4
JCP = 1.8, CH), 57.4 (s, CH2NH), 50.1 (s, NHCH2), 39.6 (t, 
1
JCP = 17.7, PCCH3), 31.2 (t, 
2
J = 3.1, CH3), 28.0 (d, 
1














 A 300 mL flask was charged 
with L-valinol (5.0 g, 48.4 mmol), 5 g of molecular sieves and 50 mL of CH2Cl2. A 
solution of 2-pyridine-carboxaldehyde (5.3 g, 49.9 mmol) and 50 mL of CH2Cl2 was 
added dropwise to the reaction flask over 10 min. with continuous stirring. The reaction 
solution was left stirring for 3 h under an open line with a continuous flow of argon. The 
solid precipitate was filtered off and CH2Cl2 was evaporated under vacuum. 100 mL of 
dry ethanol was added to the resulting clear colourless oil. The reaction flask was cooled 
in an ice bath and a suspension of NaBH4 (7.3 g, 193.9 mmol) in 50 mL of dry ethanol 
was added with continuous stirring. The reaction solution was left stirring at room 
temperature, under argon, overnight. Ethanol was then evaporated and the crude product 
was treated with 50 mL of 10 % aqueous Na2CO3 and stirred for 1 h. The product was 
extracted with 3 x 70 mL of CHCl3. The solvent was evaporated and the resulting oil 
dried under vacuum for 3 h. The product was obtained as a clear pale yellow oil (8.8 g, 
48.4 mmol, 94 %). 
1
H NMR (CHCl3): δ 8.51 (m, 1H, Py), 7.62 (m, 1H, Py), 7.25 (m, 
overlapped, 1H, Py), 7.14 (m, 1H, Py), 3.97 (dd, 
2
JHH = 14.7, 2H, PyCH2), 3.65 (dd, 
2
JHH 
= 12.0, 1H, CH2OH), 3.45 (dd, 
2
JHH = 12.0, 1H, CH2OH), 3.36 (s, 1H, NH), 2.47 (m, 1H, 
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3H, CH3), 0.90 (d, 
3





H} NMR (CHCl3): δ 160.2 (s, CN), 149.2 (s, Py), 136.8 (s, Py), 122.4 (s, Py), 
122.2 (s, Py), 65.0 (s, NHCH), 61.5 (s, CH2OH), 52.6 (s, CH2NH), 29.7 (s, CH(CH3)2), 






1-chloro-3-methyl-N-(pyridine-2-ylmethyl)butan-2-amine (5.5). A 100 mL flask was 
charged with 5.4 (2.0 g, 10.3 mmol) and 10 mL of CHCl3. The reaction solution was 
cooled in an ice bath and SOCl2 (0.8 mL, 10.8 mmol) was added dropwise over 30 min. 
with vigorous stirring. The reaction solution was left stirring in the ice bath for 10 min. 
then refluxed for 1 h at 40 
o
C. The reaction solution was then placed in the freezer for 2 h. 
The resulting solid was filtered, washed with CH2Cl2 and dried under vacuum for 2 h. 
The product was obtained as a beige solid (1.1 g, 10.3 mmol, 42 %). 
1
H NMR (DMSO): δ 
9.98 (s, 1H, NH2), 8.74 (d, 
3
JHH = 4.8, 1H, Py), 8.14 (m, 1H, Py), 7.98 (d, 
3
JHH = 7.8, 1H, 
Py), 7.65 (t, 
3
JHH = 6.0, 1H, Py), 4.57 (s, 2H, CCH2), 4.10 (m, 2H, CH2Cl), 3.41 (m, 1H, 
NHCH), 2.30 (m, 1H, CH(CH3)2), 1.04 (d, 
3
JHH = 6.9, 3H, CH3), 0.99 (d, 
3





H} NMR (DMSO): δ 150.8 (s, CN), 147.3 (s, Py), 140.8 (s, Py), 126.3 (s, 
Py), 125.5 (s, Py), 63.4 (s, NHCH), 47.9 (CH2NH), 41.4 (s, CH2Cl), 28.1 (s, CH(CH3)2), 







Cl Cl  
ZnCl2(PyCH2NHCH(CH(CH3)2)Cl. A 25 mL flask was first charged with 5.5 (200.0 
mg, 0.7 mmol), Zn powder (92.0 mg, 1.4 mmol) and 3 mL of CHCl3. The reaction 
mixture was stirred at room temperature for 4 h. The solvent was evaporated and the solid 
dried under vacuum for 4 h. The resulting product was obtained with unreacted Zn 
powder. 
1
H NMR (CHCl3): δ 8.60 (d, 
3
JHH = 5.1, 1H CN), 7.99 (m, 1H Py), 7.55 (t, 
3
JHH 
= 7.5, 1H, Py), 7.47 (d, 
3
JHH = 8.1, 1H, Py), 4.34 (m, 2H, CCH2), 3.88 (m, 2H, CH2Cl), 
3.72 (m, 1H, NH), 3.28 (m, 1H, NHCH), 2.42 (m, 1H, CH(CH3)2), 1.12 (d, 
3
JHH = 6.9, 3H, 
CH3), 1.07 (d, 
3
JHH = 6.9, 3H, CH3). 
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